Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression-Reference-Cited by-同舟云学术

Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression

Published:2009-01-06 Issue:3 Volume:30 Page:397-407
ISSN:1460-2180
Container-title:Carcinogenesis
language:en
Short-container-title:

Author:

Nikolova Viktoriya,Koo Chuay-Yeng,Ibrahim Sherif Abdelaziz,Wang Zihua,Spillmann Dorothe,Dreier Rita,Kelsch Reinhard,Fischgräbe Jeanett,Smollich Martin,Rossi Laura H.,Sibrowski Walter,Wülfing Pia,Kiesel Ludwig,Yip George W.,Götte Martin

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,General Medicine

Link

http://academic.oup.com/carcin/article-pdf/30/3/397/17286892/bgp001.pdf

Reference59 articles.

1. Functions of cell surface heparan sulfate proteoglycans;Bernfield;Annu. Rev. Biochem.,1999

2. Inhibition by the soluble syndecan-1 ectodomains delays wound repair in mice overexpressing syndecan-1;Elenius;J. Biol. Chem.,2004

3. Syndecans in inflammation;Götte;FASEB J.,2003

4. Juvenile syndecan-1 null mice are protected from carcinogen-induced tumor development;McDermott;Oncogene,2007

5. Transmembrane domains of the syndecan family of growth factor coreceptors display a hierarchy of homotypic and heterotypic interactions;Dews;Proc. Natl Acad. Sci. USA,2007

Cited by 166 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative E-cadherin and syndecan-1 protein expression in human and canine oral squamous cell carcinoma;Acta Veterinaria Hungarica;2024-01-09

2. Scientific and clinical relevance of non-cellular tumor microenvironment components in ovarian cancer chemotherapy resistance;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-01

3. Compartmental Syndecan-1 (CD138) expression as a novel prognostic marker in triple-negative metaplastic breast cancer;Pathology - Research and Practice;2024-01

4. Soluble vascular endothelial glycocalyx proteoglycans as potential therapeutic targets in inflammatory diseases;Immunology & Cell Biology;2023-11-20

5. Redox signaling-mediated tumor extracellular matrix remodeling: pleiotropic regulatory mechanisms;Cellular Oncology;2023-10-04